BATON ROUGE – Critics across the country are questioning why Dsuvia is needed. It is a new opioid and painkiller that has recently been given approval by the FDA, but many disagree and believe it is a terrible mistake.
"We are probably the worst epidemic that is the opioid epidemic in this country, which will probably kill and harm more people than any other epidemic from the country or the world they've seen," said Coroner Beau Clark.
East Baton Rouge Parish Coroner, Dr. Beau Clark has seen firsthand the deadly effects of opioid use with at least 72 overdose deaths alone in the parish this year.
"This is like a really blatant indifference to human life. We are talking about a substance, opiates that kill people because we need more when we have a problem with what we have," said Clark.
According to the FDA, there are strict instructions for the drug that dissolves in your mouth. It can only be used in hospitals, surgical centers and emergency rooms. Dsuvia should not be used for more than 72 hours and not available in pharmacies.
They say that this is a medicine that will only be given to a health care unit for a very short time in a very controlled environment. This is great if this happens. However, later in the statement, they say that this was also developed with the Ministry of Defense, so it contradicts.
In a statement from the FDA Committee, Scott Gottlieb says: "This opioid synthesis, along with the unique Dsuvia delivery device, was a priority product for the Pentagon, because it fills a specific and vital but limited unfortunate need in the treatment of our nation's soldiers battlefield, but Dr. Clark does not buy it.
"A soldier is out there who protects our country and if we are injured in the battlefield, we must have mechanisms to manage their pain, especially if they have a long transportation time from where they are injured and have permanent care, but I think these things exist already, "said Clark.
Severe risks from using Dsuvia include respiratory depression, coma and even death and not to mention the high addictive quality.
"Possession of stronger and stronger Opioids is really the wrong direction and certainly sends the wrong message." In the statement by Dr. Gottlieb for Dsuvia, added: "We will not omit what I believe is the real underlying source of dissatisfaction among the critics of this approval, the question of whether or not America needs another powerful opioid, massive addiction crisis."
Gottlieb says that this question will be addressed openly and directly. Dsuvia is going to generate annual sales of $ 1.1 billion, but Clark is more concerned with the lives that could be lost in the future.
"We are well on the way to another year record of increasing the number of opioids compared to last year and I do not see an end to vision and when we do that and we create another category of an even stronger The opioid I believe leads to more and more problems "said Clark.
For more information about Dsuvia, click here.